MedWatch

Danish Growth Fund ready for biotech investments: “We are patient and flush with funds”

Christian Motzfeldt, CEO, the Danish Growth Fund, is willing to invest more in biotechnology. He hopes that the fund can help creating Denmark’s next international biotech success and according to him, the fund can provide time and patience as well as money for the project.

Christian Motzfeldt, adm. direktør for Vækstfonden
Photo: Ricky John Molloy

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Novo Nordisk Fonden køber sig ind i børsen i Israel

Novo Nordisk Fonden er gået med i et syndikat af investorer, som står til at overtage små 40 pct. af børsen i den israelske by Tel Aviv. Det skal bane vejen for, at børsen selv bliver et børsnoteret selskab. Hos Novo Holdings ser man det som "en god langsigtet investering".

Related articles